Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tezepelumab (AMG 157)
Research
How Amgen, AZ's Tezspire holds promise for colorectal cancer
Scientists at the Benaroya Research Institute identified a subset of Treg cells that appear to fuel the development of colorectal cancer.
Angus Liu
May 18, 2022 2:00pm
Amgen, AstraZeneca move needle in hard-to-treat asthma subgroup
Sep 7, 2021 8:20am
AstraZeneca drops tezepelumab from atopic dermatitis pipeline
Jul 29, 2021 6:19am
AZ, Amgen asthma drug is 'one to watch'
Sep 7, 2017 10:10am
